Observation items | Visit 1 Screening/baseline | Visit 2 3 months ± 7 days | Visit 3 6 months ± 7 days | Visit 4 12 months ± 7 days |
---|---|---|---|---|
Informed consent | X | |||
Inclusion/exclusion | X | |||
Demographics | X | X | X | X |
Medical history | X | X | X | X |
vital signs | X | X | X | X |
Laboratory tests | X | X | X | X |
Blood gas test | X | X | X | X |
electrocardiogram | X | X | X | X |
6MWD | X | X | X | X |
WHO-FC | X | X | X | X |
Pulmonary function | X | X | ||
Echocardiography | X | X | X | |
RHC | X | X | ||
CPET | X | X | X | |
CMR | X | X | X | |
QOL (SF-36) | X | X | X | X |
Concomitant medication | X | X | X | X |
Medication adherence | X | X | X | |
Adverse events | X | X | X | X |